Literature DB >> 35962894

Identification of two potential immune-related biomarkers of Graves' disease based on integrated bioinformatics analyses.

Yihan Zhang1, Jia Wei2, Hong Zhou1, Bingxin Li1, Ying Chen1, Feng Qian3, Jingting Liu3, Xin Xie4, Huanbai Xu5.   

Abstract

BACKGROUND: Graves' disease (GD) is an autoimmune disease, the incidence of which is increasing yearly. GD requires long-life therapy. Therefore, the potential immune-related biomarkers of GD need to be studied.
METHOD: In our study, differentially expressed genes (DEGs) were derived from the online Gene Expression Omnibus (GEO) microarray expression dataset GSE71956. Protein‒protein interaction (PPI) network analyses were used to identify hub genes, which were validated by qPCR. GSEA was used to screen potential pathways and related immune cells. Next, CIBERSORT analysis was used to further explore the immune subtype distribution pattern among hub genes. ROC curves were used to analyze the specificity and sensitivity of hub genes. RESULT: 44 DEGs were screened from the GEO dataset. Two hub genes, EEF1A1 and EIF4B, were obtained from the PPI network and validated by qPCR (p < 0.05). GSEA was conducted to identify potential pathways and immune cells related to these the two hub genes. Immune cell subtype analysis revealed that hub genes had extensive associations with many different types of immune cells, particularly resting memory CD4+ T cells. AUCs of ROC analysis were 0.687 and 0.733 for EEF1A1 and EIF4B, respectively.
CONCLUSION: Our study revealed two hub genes, EEF1A1 and EIF4B, that are associated with resting memory CD4+ T cells and potential immune-related molecular biomarkers and therapeutic targets of GD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Differentially expressed genes; Graves’ disease; Immune cell infiltration analysis; Resting memory CD4+ T cells

Mesh:

Substances:

Year:  2022        PMID: 35962894     DOI: 10.1007/s12020-022-03156-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  29 in total

Review 1.  Graves' Disease.

Authors:  Terry J Smith; Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2016-10-20       Impact factor: 91.245

2.  Graves' Disease.

Authors:  Terry J Smith; Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2017-01-12       Impact factor: 91.245

Review 3.  Toll-Like Receptor Pathways in Autoimmune Diseases.

Authors:  Ji-Qing Chen; Peter Szodoray; Margit Zeher
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 4.  Global epidemiology of hyperthyroidism and hypothyroidism.

Authors:  Peter N Taylor; Diana Albrecht; Anna Scholz; Gala Gutierrez-Buey; John H Lazarus; Colin M Dayan; Onyebuchi E Okosieme
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 5.  Graves' disease.

Authors:  Terry F Davies; Stig Andersen; Rauf Latif; Yuji Nagayama; Giuseppe Barbesino; Maria Brito; Anja K Eckstein; Alex Stagnaro-Green; George J Kahaly
Journal:  Nat Rev Dis Primers       Date:  2020-07-02       Impact factor: 52.329

Review 6.  Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection.

Authors:  Wei Gu; Steve Miller; Charles Y Chiu
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 7.  Hyperthyroidism.

Authors:  Simone De Leo; Sun Y Lee; Lewis E Braverman
Journal:  Lancet       Date:  2016-03-30       Impact factor: 79.321

8.  Epigenetic profiling in CD4+ and CD8+ T cells from Graves' disease patients reveals changes in genes associated with T cell receptor signaling.

Authors:  Maia Limbach; Mario Saare; Liina Tserel; Kai Kisand; Triin Eglit; Sascha Sauer; Tomas Axelsson; Ann-Christine Syvänen; Andres Metspalu; Lili Milani; Pärt Peterson
Journal:  J Autoimmun       Date:  2015-10-12       Impact factor: 7.094

9.  Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China.

Authors:  Yayi He; Jie Zheng; Qian Zhang; Peng Hou; Feng Zhu; Jian Yang; Wenhao Li; Pu Chen; Shu Liu; Bao Zhang; Bingyin Shi
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

10.  Treatment of Graves' ophthalmopathy with an in-house Phosphorus-32 source: Initial clinical observations.

Authors:  Hai-Tao Hao; Yujun Wang; Xufu Wang; Sha Luan; Jianhua Cui; Yu Chen; Ya-Li Cui
Journal:  Exp Ther Med       Date:  2017-08-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.